۲۱ | Evaluating human epidermal growth factor receptor 2 roles in the efficacy of Tamoxifen treatment in breast cancer, a systematic review | Mansouri, S., Mokhtari-Hesari, P., Naghavi-al-Hosseini, F., (...), Ghahremanlou, M., Farahmand, L. | Pharmacological Reports | 2021 |
۲۲ | Necroptosis triggered by ROS accumulation and Ca2+ overload, partly explains the inflammatory responses and anti-cancer effects associated with 1Hz, 100 mT ELF-MF in vivo | Barati, M., Javidi, M.A., Darvishi, B., (...), Farahmand, L., Madjid Ansari, A. | Free Radical Biology and Medicine | 2021 |
۲۳ | Development of a recombinant anti-VEGFR2-EPCAM bispecific antibody to improve antiangiogenic efficiency | Barzaman, K., Samadi, M., Moradi-kalbolandi, S., (...), Shekarabi, M., Farahmand, L. | Experimental Cell Research | 2021 |
۲۴ | Breast cancer immunotherapy: Current and novel approaches | Barzaman, K., Moradi-Kalbolandi, S., Hosseinzadeh, A., (...), Safari, E., Farahmand, L. | International Immunopharmacology | 2021 |
۲۵ | The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development | Moradi-kalbolandi, S., Majidzadeh-A, K., Abdolvahab, M.H., Jalili, N., Farahmand, L. | Probiotics and Antimicrobial Proteins | 2021 |
۲۶ | Engineered hypoxia-responding Escherichia coli carrying cardiac peptide genes, suppresses tumor growth, angiogenesis and metastasis in vivo | Samadi, M., Majidzadeh-A, K., Salehi, M., (...), Moradi-Kalbolandi, S., Farahmand, L. | Journal of Biological Engineering | 2021 |
۲۷ | Triple-negative breast cancer: understanding Wnt signaling in drug resistance | Merikhian, P., Eisavand, M.R., Farahmand, L. | Cancer Cell International | 2021 |
۲۸ | The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker | Darvishi, B., Boroumandieh, S., Majidzadeh-A, K., (...), Jafari, F., Farahmand, L. | Experimental and Molecular Pathology | 2020 |
۲۹ | Interferons: Role in cancer therapy | Abdolvahab, M.H., Darvishi, B., Zarei, M., Majidzadeh-A, K., Farahmand, L. | Immunotherapy | 2020 |
۳۰ | Anticancer potentiality and mode of action of low-carbohydrate proteins and peptides from mushrooms | Rezvani, V., Pourianfar, H.R., Mohammadnejad, S., Madjid Ansari, A., Farahmand, L. | Applied Microbiology and Biotechnology | 2020 |
۳۱ | Enhancement of extracellular bispecific anti-MUC1 nanobody expression in E. coli BL21 (DE3) by optimization of temperature and carbon sources through an autoinduction condition | Rezaei, L., Shojaosadati, S.A., Farahmand, L., Moradi-Kalbolandi, S. | Engineering in Life Sciences | 2020 |
۳۲ | Breast cancer: Biology, biomarkers, and treatments | Barzaman, K., Karami, J., Zarei, Z., (...), Safari, E., Farahmand, L. | International Immunopharmacology | 2020 |
۳۳ | Dual in vitro invasion/migration suppressing and tamoxifen response modulating effects of a recombinant anti-ALCAM scFv on breast cancer cells | Darvishi, B., Salehi, M., Boroumandieh, S., (...), Moradi-Kalbolandi, S., Farahmand, L. | Cell Biochemistry and Function | 2020 |
۳۴ | Evaluation the potential of recombinant anti-CD3 nanobody on immunomodulatory function | Moradi-Kalbolandi, S., Sharifi-K, A., Darvishi, B., (...), Salehi, M., Farahmand, L. | Molecular Immunology | 2020 |
۳۵ | Development of an anti-CD45RA-quantum dots conjugated scFv to detect leukemic cancer stem cells | Moradi-Kalbolandi, S., Dashtestani, F., Salehi, M., (...), Yadegari, A., Farahmand, L. | Molecular Biology Reports | 2020 |
۳۶ | The antiproliferative effects of cold atmospheric plasma-activated media on different cancer cell lines, the implication of ozone as a possible underlying mechanism | Mokhtari, H., Farahmand, L., Yaserian, K., Jalili, N., Majidzadeh-A, K. | Journal of Cellular Physiology | 2019 |
۳۷ | Functional investigation of the BRCA1 Val1714Gly and Asp1733Gly variants by computational tools and yeast transcription activation assay | Yadegari, F., Farahmand, L., Esmaeili, R., Samadi, T., Majidzadeh, K. | Molecular Biology Research Communications | 2019 |
۳۸ | The prognostic value of circulating tumor cells in primary breast cancer prior to any systematic therapy: A systematic review | Mansouri, S., Mokhtari-Hesari, P., Naghavi-Al-Hosseini, F., Keivan Majidzadeh, A., Farahmand, L. | Current Stem Cell Research and Therapy | 2019 |
۳۹ | Tumor-suppressing and anti-angiogenic activities of a recombinant anti-CD3ϵ nanobody in breast cancer mice model | Khatibi, A.S., Roodbari, N.H., Majidzade-A, K., Yaghmaei, P., Farahmand, L. | Immunotherapy | 2019 |
۴۰ | Challenges facing antiangiogenesis therapy: The significant role of hypoxia-inducible factor and MET in development of resistance to anti-vascular endothelial growth factor-targeted therapies | Mahdi, A., Darvishi, B., Majidzadeh-A, K., Salehi, M., Farahmand, L. | Journal of Cellular Physiology | 2019 |